Corresponding author:
Connor Prosty, B.Sc.
1001 Decarie Blvd, Montréal
Québec, H4A 3J1
Email: connor.prosty@mail.mcgill.ca
Phone: 514-934-1934 ext. 23151
Fax: 514-412-4390
Article Type: Original Manuscript
Funding Sources: This article has no funding source.
Conflict of Interest: Luis F. Ensina is a consultant and speaker for Novartis, Takeda, Sanofi, and Abbvie and is involved in clinical trials with Novartis. Elena Netchiporouk is a consultant and speaker for Novartis and has received an investigator-initiated research grant from Novartis. Moshe Ben-Shoshan is a consultant for Novartis and Sanofi. The other authors declare no conflicts of interest.
Manuscript word count: 2295
Abstract word count: 213
References: 28
Figures/Tables: 4
Reprint request: Reprints not available from the authors.